基本信息
views: 71
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Current Research and Scholarly Interests
Understanding organ development and achieving functional restoration of diseased organs is a broad goal motivating effort in our group. Pancreatic islets of Langerhans, endocrine organs that secrete insulin and glucagon, have emerged as a paradigm for investigating both organ development and restoration. Deficiency of insulin-producing islet β-cells or their function underlies the pathogenesis of diabetes mellitus, a disease with devastating autoimmune (type 1), pandemic (type 2), and exocrine-associated (type 3c) forms. However, islet replacement, or preservation in diabetes, is ultimately limited by our inadequate understanding of mechanisms controlling islet formation, growth and immunological protection. To discover these mechanisms, my laboratory is using a combination of genetic, developmental, immunological, physiological and genomic approaches in different experimental systems, with a focus on several fundamental questions:
What are the cellular, molecular, signaling and genetic mechanisms regulating pancreatic development and functional maturation?
Can we harness our growing understanding of pancreatic islet development to generate replacement islets for diabetes, including islet cells generated from human stem cell lines?
What are the genetic programs underlying diabetes risk?
What immunological and transplantation paradigms can be developed to protect native or replacement islets in type 1 diabetes?
Can we advance understanding of normal pancreas development and function to discover the basis of devastating exocrine pancreatic diseases, including pancreatic cancer?
To address these challenges, our group has developed new approaches in mice, fruit flies, pigs, primary human pancreatic cells, and multipotent human stem cells. Each of these systems offers different experimental advantages. Discoveries from our systems have created unprecedented opportunities for harnessing knowledge about pancreatic development and growth to restore pancreas islet function, and to identify the molecular, genetic, signaling, and immune basis of pancreatic diseases like diabetes mellitus, pancreatitis and pancreatic cancer.
Understanding organ development and achieving functional restoration of diseased organs is a broad goal motivating effort in our group. Pancreatic islets of Langerhans, endocrine organs that secrete insulin and glucagon, have emerged as a paradigm for investigating both organ development and restoration. Deficiency of insulin-producing islet β-cells or their function underlies the pathogenesis of diabetes mellitus, a disease with devastating autoimmune (type 1), pandemic (type 2), and exocrine-associated (type 3c) forms. However, islet replacement, or preservation in diabetes, is ultimately limited by our inadequate understanding of mechanisms controlling islet formation, growth and immunological protection. To discover these mechanisms, my laboratory is using a combination of genetic, developmental, immunological, physiological and genomic approaches in different experimental systems, with a focus on several fundamental questions:
What are the cellular, molecular, signaling and genetic mechanisms regulating pancreatic development and functional maturation?
Can we harness our growing understanding of pancreatic islet development to generate replacement islets for diabetes, including islet cells generated from human stem cell lines?
What are the genetic programs underlying diabetes risk?
What immunological and transplantation paradigms can be developed to protect native or replacement islets in type 1 diabetes?
Can we advance understanding of normal pancreas development and function to discover the basis of devastating exocrine pancreatic diseases, including pancreatic cancer?
To address these challenges, our group has developed new approaches in mice, fruit flies, pigs, primary human pancreatic cells, and multipotent human stem cells. Each of these systems offers different experimental advantages. Discoveries from our systems have created unprecedented opportunities for harnessing knowledge about pancreatic development and growth to restore pancreas islet function, and to identify the molecular, genetic, signaling, and immune basis of pancreatic diseases like diabetes mellitus, pancreatitis and pancreatic cancer.
Research Interests
Papers共 513 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Insung Park,Sergio Navarro-Serna, Sergio Navarro-Serna,Raquel M. Pinho,Trish Berger,Elizabeth A. Maga, Joaqu?n Gadea, Joaqu?n Gadea,Seung K. Kim, Seung K. Kim, Seung K. Kim,Pablo J. Ross
Re:GEN Openno. 1 (2024): 9-20
Diabetesno. 3 (2024): 448-460
DIABETESno. 3 (2024): 448-460
Xiangni Wu, Pin-I Chen,Robert L. Whitener, Matthew S. MacDougall,Vy M. N. Coykendall, Hao Yan, Yong Bin Kim, William Harper,Shiva Pathak,Bettina P. Iliopoulou, Allison Hestor,Diane C. Saunders,
Frontiers in Immunology (2024)
G3 (Bethesda, Md.)no. 2 (2024)
Lutz Kockel,Valentina Zhang, Jenna Wang,Clara Gulick,Madeleine E Laws,Arjun Rajan,Nicole Lantz, Ayla Asgarova,Lillian Dai,Kristian Garcia, Charlene Kim, Michelle Li,
bioRxiv : the preprint server for biology (2024)
bioRxiv (Cold Spring Harbor Laboratory) (2023)
bioRxiv (Cold Spring Harbor Laboratory) (2023)
biorxiv(2023)
Load More
Author Statistics
#Papers: 513
#Citation: 41159
H-Index: 104
G-Index: 186
Sociability: 8
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn